Francesco Crescenzo

13PUBLICATIONS
40CO-AUTHORS
Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Medical infection agents (incl. prions)Cardiology (incl. cardiovascular diseases)Computational neuroscience (incl. mathematical neuroscience and theoretical neuroscience)Predictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (13)

|Aug 04, 2025
Eculizumab as Additional Rescue Therapy in Myasthenic Crisis.

Francesco Crescenzo, Mattia Zanoni, Laura Ferigo

|May 01, 2025
Intrathecal Inflammatory Profile and Gray Matter Damage Predict Progression Independent of Relapse Activity in Early Multiple Sclerosis.

Damiano Marastoni, Elisa Colato, Matteo Foschi

|Nov 04, 2024
Early regional cerebral grey matter damage predicts long-term cognitive impairment phenotypes in multiple sclerosis: a 20-year study.

Stefano Ziccardi, Francesco Crescenzo, Maddalena Guandalini

|Jan 24, 2023
Cortical lesions at diagnosis predict long-term cognitive impairment in multiple sclerosis: A 20-year study.

Stefano Ziccardi, Anna Isabella Pisani, Gian Marco Schiavi

|Dec 23, 2022
Immune Response after COVID-19 mRNA Vaccination in Multiple Sclerosis Patients Treated with DMTs.

Valentina Mazziotti, Francesco Crescenzo, Agnese Tamanti

Pageof 3